FDA issued a Warning Letter to Alexion Pharmaceuticals, Inc. on 3/22/2013 for a previous inspection.
483 Alexion Pharmaceuticals Jul 2017

483 Alexion Pharmaceuticals Jul 2017

Jose Hernandez FDA, Nealie Newberger FDA$595.00 - Available Now

FDA investigators audited the Alexion Pharmaceuticals - Smithfield, RI, United States facility and issued inspectional observations (via FDA 483) on 21 Jul 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Jul 2017
  • Location: Smithfield, United States
  • FEI: 3006568549
Add To Cart